| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $23.26B | $23.31B | $23.47B |
| YoY Revenue Growth % | -0.2% | -0.7% | — |
| Gross Profit | $1.50B | $1.64B | — |
| Gross Margin % | 6.5% | 7.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $777.3M | $887.7M | $933.2M |
| Operating Margin % | 3.3% | 3.8% | 4.0% |
| Net Income (GAAP) | $436.8M | $506.6M | $572.5M |
| EBITDA (Normalized) | $1.23B | $1.33B | $1.78B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.09B | $1.12B | $1.25B |
| Capital Expenditures (CapEx) | $561.6M | $558.7M | $1.06B |
| Free Cash Flow (FCF) | $527.2M | $561.4M | $193.3M |
| FCF Margin % | 2.3% | 2.4% | 0.8% |
| Return on Invested Capital (ROIC %) | 8.2% | 10.5% | 4.3% |
| Cash & Short-Term Equivalents | $1.03B | $1.05B | — |
| Total Debt (Short + Long Term) | $3.47B | $3.28B | $6.59B |
| Total Stockholders' Equity | $5.04B | $4.45B | $13.52B |